» Articles » PMID: 15771276

Tissue Ablation with Irreversible Electroporation

Overview
Journal Ann Biomed Eng
Date 2005 Mar 18
PMID 15771276
Citations 446
Authors
Affiliations
Soon will be listed here.
Abstract

This study introduces a new method for minimally invasive treatment of cancer-the ablation of undesirable tissue through the use of irreversible electroporation. Electroporation is the permeabilization of the cell membrane due to an applied electric field. As a function of the field amplitude and duration, the permeabilization can be reversible or irreversible. Over the last decade, reversible electroporation has been intensively pursued as a very promising technique for the treatment of cancer. It is used in combination with cytotoxic drugs, such as bleomycin, in a technique known as electrochemotherapy. However, irreversible electroporation was completely ignored in cancer therapy. We show through mathematical analysis that irreversible electroporation can ablate substantial volumes of tissue, comparable to those achieved with other ablation techniques, without causing any detrimental thermal effects and without the need of adjuvant drugs. This study suggests that irreversible electroporation may become an important and innovative tool in the armamentarium of surgeons treating cancer.

Citing Articles

A preliminary follow-up study on irreversible electroporation therapy in older patients with prostate cancer.

Xia Z, Yang J, Xiao F, Xu J, Zhong X, Wang S Discov Oncol. 2025; 16(1):278.

PMID: 40053175 PMC: 11889298. DOI: 10.1007/s12672-025-02025-0.


Pulsed field ablation in medicine: irreversible electroporation and electropermeabilization theory and applications.

Jacobs E, Rubinsky B, Davalos R Radiol Oncol. 2025; 59(1):1-22.

PMID: 40014783 PMC: 11867574. DOI: 10.2478/raon-2025-0011.


Round Well Inset for Uniform Electric Field Distribution in Electroporation Applications.

Sahu P, Barozzi M, Di Barba P, Mognaschi M, La Mura M, Lamberti P Bioengineering (Basel). 2025; 12(2).

PMID: 40001722 PMC: 11851808. DOI: 10.3390/bioengineering12020203.


Focal Therapy for Prostate Cancer: Recent Advances and Insights.

Lasorsa F, Biasatti A, Orsini A, Bignante G, Farah G, Pandolfo S Curr Oncol. 2025; 32(1).

PMID: 39851931 PMC: 11764426. DOI: 10.3390/curroncol32010015.


Study protocol for a single-centre non-inferior double-blinded randomised controlled trial in China comparing the efficacy and safety of high-frequency irreversible electroporation with transurethral resection of the prostate in treating lower....

He B, Shi Z, Chen R, Wang H BMJ Open. 2025; 15(1):e092489.

PMID: 39788775 PMC: 11751931. DOI: 10.1136/bmjopen-2024-092489.